Description
HER2/neu (869-877) is a peptide fragment of the HER2/neu receptor, also known as CD340, EGFR2, or erbB2. This receptor exhibits anti-apoptotic activity and is associated with breast and other cancers.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HER2/neu (869-877) is a peptide fragment of the HER2/neu receptor, also known as CD340, EGFR2, or erbB2. This receptor exhibits anti-apoptotic activity and is associated with breast and other cancers.
| Purity | ≥95% |
|---|---|
| Formula | C49H75N9O20 |
| Formula Wt. | 1110.19 |
| Synonym | ErbB2, EGFR2 |
| Solubility | Soluble in water. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Mitri Z, Constantine T, O'Regan R. The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy. Chemother Res Pract. 2012;2012:743193. PMID: 23320171.
Roy V, Perez EA. Beyond trastuzumab: small molecule tyrosine kinase inhibitors in HER-2-positive breast cancer. Oncologist. 2009 Nov;14(11):1061-9. PMID: 19887469.
Prolyl hydroxylase inhibitor.
Phytoestrogen, isoflavone found in various plan...
Sulfonamide; PABA inhibitor.
Endogenous neuropeptide hormone, lowers extrace...
Endogenous sterol component of animal cell memb...
NSAID; COX-2 inhibitor.
Phenol found in Zingiber; PPARγ agonist, 5-HT3...
Selective inhibitor of LRRK2.
Folic acid derivative
VEGFR inhibitor.
Isoquinoline alkaloid found in a variety of pla...
Neuropeptide found in Schistocera gregaria.
Histamine H1 antagonist.
β2-adrenergic agonist.
FIASMA; α1- and β1/2-adrenergic antagonist.
SERM.
PERK inhibitor.
TGFbeta receptor inhibitor
Carcinoembryonic antigen epitope.
Peptide; fibrinolysis inhibitor.